Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 3, 1999, Pages 297-301

  Ribeiro, A L P ^a   Drummond, J B ^a   Volpini, A C ^b   Andrade, A C ^b   Passos, V M A ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cutaneous leishmaniasis; Electrocardiography; QT interval

Indexed keywords

MEGLUMINE;

ADULT; AGED; ARTICLE; BRAZIL; CARDIOTOXICITY; DOSE TIME EFFECT RELATION; DRUG EFFECT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; QT INTERVAL; SKIN LEISHMANIASIS; SUDDEN DEATH;

EID: 0032924139     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x1999000300008     Document Type: Article

References (15)

1. Marzochi MCA (1992). Leishmanioses no Brasil. As leishmanioses tegumentares. Jornal Brasileiro de Medicina, 63: 82-104.
2. Pearson DR & Souza AO (1996). Leishmaniasis. In: Bennett JC & Plum F (Editors), Cecil Textbook of Medicine. 20th edn. W.B. Saunders, Philadelphia.
3. Falqueto A & Sessa PA (1991). Leishmaniose tegumentar amencana. In: Focaccia R & Dietze R (Editors), Veronesi Doenças Infecciosas e Parasitárias. 8th edn. Guanabara Koogan, Rio de Janeiro.
4. Pearson RD & Souza AQ (1990). Leishmania species: visceral (kala-azar), cutaneous, and mucosal leishmamasis. In: Mandell GL, Douglas RG & Bennett JE (Editors), Principles and Practice of Infectious Diseases. 3rd edn. Churchill Livingstone, New York
5. Sampaio RNR, Neto EM, Fatia EA, Sampaio JHD, Freitas LC & Marsden PD (1988). Morte súbita causada por glucantime. Anais Brasileiros de Dermatologia, 63: 35-37.
6. Chulay JD, Spencer HC & Mugambi M (1985). Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). American Journal of Tropical Medicine and Hygiene, 34: 702-709.
7. Katlama C, Régnier B, Ben Salah N, Pichard E & Vanchon F (1985). Toxicité du Glucantime. Une observation. Annales de Medicine Interne, 136: 321-322.
8. Muller RG, Valera M, Carrasco H, Fuenmayor A, Benedetti JR, Torrealba W & Mendonza E (1982). Vanacion electrocardiográfica de la cardiotoxicidad del antimoniato de N-metil glucammina (R Glucantime). Archivos del Instituto de Cardiologia de Mexico, 52: 155-159.
9. Saenz RE, Paz HM, Johnson CM, Narvaez E & Vásquez AM (1987). Evaluacion de la efectividad y toxicidad del pentostam y del glucantime en el tratamiento de la leishmaniasis cutanea. Revista Médica de Panamá, 12: 148-157.
10. Lacerda Ju̇nior FS, Germiniani H, Mota CCS & Baranski MC (1965). Estudo comparativo das alteraçōes eletrocardiográficas determinadas pelo tratamento com antimoniais tri e pentavalentes. Revista do Instituto de Medicina Tropical de São Paulo, 7: 210-217.
11. Antezana G, Zeballos R, Mendonza C, Lyevre P, Valda L, Cardenas F, Noriega I, Ugarte H & Decet P (1992). Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86: 31-33.
12. Navin TR, Arana BA, Arana FE, Berman JD & Chajȯn JF (1992). Placebo-controlled clinical trial of sodium stibogluconate (pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. Journal of Infectious Diseases, 165: 528-534.
13. Passos VMA, Volpini AC, Braga EM, Lacerda PAF, Ouaissi A, Lima-Martins MVC & Krettli AU (1997) Differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp. using ELISA with a recombinant antigen (rTc24). Memórias do Institute Oswaldo Cruz, 92: 791-793.
14. Woosley RL & Sale M (1993). QT interval: a measure of drug action. American Journal of Cardiology, 72: 36B-43B.
15. Schoeneberger RA, Haefeli WE, Weiss P & Ritz RF (1990). Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes). British Medical Journal, 300: 1375-1376.